NF1 and RASopathy: In subjects with a clinical suspicion of a RASopathy or neurocutaneous disorder, the mutation detection rate was 72.2% (26/36), with variants distributed in ten different genes, mainly PTPN11 (22.2%), and with only one causative variant in NF1 (2.7%).